Whether to maintain a woman's psychiatric drug regimen when she becomes pregnant is a delicate decision that must consider the benefits and risks to both mother and child. With little research exploring the safety of mood stabilizers and like medications during pregnancy, the knee-jerk reaction for many years has been to suspend the prescriptions. A review of studies published between January 2000 and December 2014, however, reveals that most psychotropic drugs are relatively safe for use in expecting women. Moreover, the review authors conclude, any risk presented by continuing use of these medications during pregnancy is eclipsed by the risk associated with discontinuing them. A high proportion of women with conditions such as bipolar disorder and schizophrenia relapse if they stop taking their prescriptions during the gestation period. That, in turn, can lead to unfavorable outcomes, including suicide and infanticide.